Abstract:Biologically compatible vascular grafts are urgently required. The scaffoldless multi-layered vascular wall is considered to offer theoretical advantages, such as facilitating cells to form cell-cell and cell-matrix junctions and natural extracellular matrix networks. Simple methods are desired for fabricating physiological scaffoldless tissue-engineered vascular grafts. Here, we showed that periodic hydrostatic pressurization under hypoxia (HP/HYP) facilitated the fabrication of multi-layered tunica media entirely from human vascular smooth muscle cells. Compared with normoxic atmospheric pressure, HP/HYP increased expression of N-myc downstream-regulated 1 (NDRG1) and the collagen-cross-linking enzyme lysyl oxidase in human umbilical artery smooth muscle cells. HP/HYP increased N-cadherin-mediated cell-cell adhesion via NDRG1, cell-matrix interaction (i.e., clustering of integrin α5β1 and fibronectin), and collagen fibrils. We then fabricated vascular grafts using HP/HYP during repeated cell seeding and obtained 10-layered smooth muscle grafts with tensile rupture strength of 0.218-0.396 MPa within 5 weeks. Implanted grafts into the rat aorta were endothelialized after 1 week and patent after 5 months, at which time most implanted cells had been replaced by recipient-derived cells. These results suggest that HP/HYP enables fabrication of scaffoldless human vascular mimetics that have a spatial arrangement of cells and matrices, providing potential clinical applications for cardiovascular diseases. STATEMENT OF SIGNIFICANCE: Tissue-engineered vascular grafts (TEVGs) are theoretically more biocompatible than prosthetic materials in terms of mechanical properties and recipient cell-mediated tissue reconstruction. Although some promising results have been shown, TEVG fabrication processes are complex, and the ideal method is still desired. We focused on the environment in which the vessels develop in utero and found that mechanical loading combined with hypoxia facilitated formation of cell-cell and cell-matrix junctions and natural extracellular matrix networks in vitro, which resulted in the fabrication of multi-layered tunica media entirely from human umbilical artery smooth muscle cells. These scaffoldless TEVGs, produced using a simple process, were implantable and have potential clinical applications for cardiovascular diseases.

Insulin-transferrin-selenium promote formation of tissue-engineered vascular grafts in early stage of culture

3D printed VEGF-CPO biomaterial scaffold to promote subcutaneous vascularization and survival of transplanted islets for the treatment of diabetes

Engineering Vascular Tissue with Functional Smooth Muscle Cells Derived from Human Ips Cells and Nanofibrous Scaffolds.

Construction of Tissue-Engineered Vascular Grafts with High Patency by Mimicking Immune Stealth and Blocking TGF-β Mediated Endothelial-to-mesenchymal Transition

Enhancing small diameter tissue engineered vascular grafts with heparin and hepatocyte growth factor: A promising approach

Primary Experimental Study on the Construction of Tissue Engineering Blood Vessel

Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model

Construction of Biomimetic Vascular Network Applied to a Tissue-Engineered Liver Scaffold with Computer Assisted

Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors

VEGF Combined with DAPT Promotes Tissue Regeneration and Remodeling in Vascular Grafts.

Hydrostatic pressure under hypoxia facilitates fabrication of tissue-engineered vascular grafts derived from human vascular smooth muscle cells in vitro

The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft.

Tissue engineered vascular grafts: current state of the field

In Vitro and in Vivo Evaluation of Biohybrid Tissue-Engineered Vascular Grafts with Transformative 1 H/ 19 F MRI Traceable Scaffolds

In Vitro Study of Endothelial Cells Lining Vascular Grafts Grown Within the Recipient's Peritoneal Cavity.

Development And In Vivo Evaluation Of Small-Diameter Vascular Grafts Engineered By Outgrowth Endothelial Cells And Electrospun Chitosan/Poly(Epsilon-Caprolactone) Nanofibrous Scaffolds

A Facile Strategy for Fabricating Tissue Engineering Scaffolds with Sophisticated Prevascularized Networks for Bulk Tissue Regeneration

Development of a Silk Fibroin-Small Intestinal Submucosa Small-Diameter Vascular Graft with Sequential VEGF and TGF-<i></i>1 Inhibitor Delivery for In Situ Tissue Engineering

Effects of pre-vascularization of tissue-engineered constructs on the survival of transplanted pancreaticislets

Tissue Engineering of Small-Diameter Vascular Grafts by Endothelial Progenitor Cells Seeding Heparin-Coated Decellularized Scaffolds.